Grand Pharma Patents – Key Insights and Stats

Grand Pharma has a total of 778 patents globally, out of which 459 have been granted. Of these 778 patents, more than 76% patents are active. China is where Grand Pharma has filed the maximum number of patents, followed by United States of America and Europe. Parallelly, China seems to be the main focused R&D centre of Grand Pharma.

Grand Pharma was founded in the year 1995. Company operates as an international pharmaceutical company. It develops anti-tumor and cardiovascular emergency pharmaceutical products, cerebro-cardiovascular intervention medical devices, bio-health products, and more. As of August 2022, Grand Pharma has a market cap of $14.8 Billion.

Do read about some of the most popular patents of Grand Pharma which have been covered by us in this article and also you can find Grand Pharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Grand Pharma patent portfolio.

How many patents does Grand Pharma have?

Grand Pharma has a total of 778 patents globally. These patents belong to 609 unique patent families. Out of 778 patents, 594 patents are active.

How Many Patents did Grand Pharma File Every Year?

Grand Pharma Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantGrand Pharma Applications FiledGrand Pharma Patents Granted
20112515
20122812
20133626
20142523
20152826
20168423
20174817
20188418
20199335
20208641
20217779
2022960

How many Grand Pharma patents are Alive/Dead?

Grand Pharma Patent Portfolio

How Many Patents did Grand Pharma File in Different Countries?

Grand Pharma Worldwide Patent Filing

Countries in which Grand Pharma Filed Patents

CountryPatents
China593
United States Of America38
Europe21
Japan15
Hong Kong (S.A.R.)14
Canada9
Australia8
Germany6
Singapore5
Korea (South)5
Spain4
Denmark4
Taiwan4
Poland4
Brazil4
India4
Israel4
Mexico3
Norway2
Argentina1

Where are Research Centres of Grand Pharma Patents Located?

R&D Centres of Grand Pharma

10 Best Grand Pharma Patents

US6347247B1 is the most popular patent in the Grand Pharma portfolio. It has received 402 citations so far from companies like Scimed Life Systems, Cardiac Pacemakers, and Ardian.

Below is the list of 10 most cited patents of Grand Pharma:

Publication NumberCitation Count
US6347247B1402
US6865416B2393
US6516223B2249
US7171264B1177
US6520950B1115
US6567694B2103
US6763264B292
US6418341B172
US6451002B168
US20150297887A165

EXCLUSIVE INSIGHTS COMING SOON!

What are Grand Pharma’s key innovation segments?

What Technologies are Covered by Grand Pharma?

This image has an empty alt attribute; its file name is Tech-Area-Blur-22-1024x576.webp

The chart below distributes patents filed by Grand Pharma in different countries on the basis of the technology protected in patents. It also represents the markets where Grand Pharma thinks it’s important to protect particular technology inventions.

This image has an empty alt attribute; its file name is Tech-Protected-blur-22-1024x576.jpg

R&D Focus: How Grand Pharma’s search focus changed over the years?

This image has an empty alt attribute; its file name is Technology-Through-the-year-Blur-22-1024x576.jpg

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Grand Pharma?

Updated on August 22, 2022

Was this article helpful?

Leave a Comment